I heard a rumor for a more on focus r&d vs clinical studies for the next FY +.
7 replies (most recent on top)
There will be a major restructuring in clinical and medical science. Keep an eye out week of May 6th.
I always thought clinical studies were a later stage of R&D. Seems to me there are still alot of unknowns and possible changes to the product/therapy from first in man to pivotal clinical studies.
On the other hand, I would hope that clinical studies can be more streamlined than those used to get renal denervation approved. Lots of time and money for a minimally effective therapy that only works in about 1/3 of patients. I have to laugh every time LinkedIn reports a new first time denervation at a US site. Must be up 5-10 by now despite special cost-savings FDA designation!
Engineering the extraordinaire without R&D? Yes, that makes a lot of sense.
Has Ken Washington been working on anything?
Weird, I keeping hearing R&D projects are being cancelled.
FY 26 R&D budgets cut 5% across the board
Impossible. How would that move the needle in the short term? Unless the “R&D” that you speak of is M&A.